Libo Pharma Corp.

Private

TaipeiHealthcare & Life Scienceshttps://libopharma.com/

Last Round

Series C

Jul 21, 2025

Total Funding Raised

$29.33M

Company Overview

Libo Pharma Corp. is a biotechnology company that operates as a biopharmaceutical innovation incubator developing novel protein therapeutics and immunotherapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Application

Keywords

NRDOvirtual biotechdrug developmentclinical developmentoncologyimmunotherapeuticsasset-centric biotechcytokine therapymedical countermeasureInterleukin-12IL-12Acute Radiation SyndromeARSCutaneous T-cell lymphomaCTCLdrug licensinghematologyregenerative medicineAI in drug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Libo Pharma Corp. Comps

Public and private peers based on sector, stage, and business model.

Libo Pharma Corp. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Libo Pharma Corp. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Jul 21, 2025
Series B	Mar 1, 2024
Seed	Jun 1, 2017

View all Funding Rounds

Libo Pharma Corp. Investors

Notable investors and investment history

Libo Pharma Corp. investors
Investor	Rounds
CTBC Venture Capital	Series C
Beiley Biofund	Series C

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 27, 2026
Monthly visitors increased 790% MoM.

View all signals

Libo Pharma Corp. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Libo Pharma Corp. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Libo Pharma Corp.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTaipei

Employee Range16

Year Founded2017

Last FundingJul 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.